Share Price and Basic Stock Data
Last Updated: October 10, 2025, 1:46 am
| PEG Ratio | 0.20 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
HCP Plastene Bulkpack Ltd operates in the packaging and containers sector, with reported sales of ₹351 Cr for the financial year ending March 2023, a significant increase from ₹112 Cr in March 2022. The revenue trend shows an upward trajectory, with trailing twelve months (TTM) sales rising to ₹484 Cr. The company’s quarterly sales data indicates fluctuations, with a peak of ₹125.75 Cr in June 2025 and a low of ₹59.37 Cr in June 2023. This volatility suggests a potential seasonal impact or operational challenges. The reported operating profit margin (OPM) for June 2025 stood at 7.28%, reflecting improved efficiency compared to earlier quarters, particularly the low of 2.32% in June 2023. The increase in sales and operating profit highlights the company’s ability to navigate market challenges and leverage growth opportunities, although the declining sales from ₹351 Cr in March 2023 to ₹295 Cr in March 2024 raises concerns about sustainability.
Profitability and Efficiency Metrics
HCP Plastene reported a net profit of ₹13 Cr for the financial year ending March 2025, a notable recovery from the net losses recorded in the previous years, including a loss of ₹2 Cr in March 2022. The earnings per share (EPS) also saw a substantial increase, reaching ₹12.51 in March 2025 compared to a negative ₹2.39 in March 2022. The return on equity (ROE) was reported at 16.15%, indicating effective management of shareholder funds, while return on capital employed (ROCE) improved to 28.33%. However, the company’s cash conversion cycle (CCC) stood at 133 days, which is relatively high and may indicate inefficiencies in inventory management and collections. The interest coverage ratio (ICR) improved to 2.73x, reflecting better profitability relative to interest obligations, but this remains a point to monitor as it suggests the company is still in a leveraged position. Overall, while profitability metrics show positive trends, efficiency issues related to CCC could hinder operational performance.
Balance Sheet Strength and Financial Ratios
The balance sheet of HCP Plastene reveals a total borrowing of ₹190 Cr against reserves of ₹49 Cr as of March 2025, indicating a significant reliance on debt financing. The debt-to-equity ratio stood at 3.19, which is notably high and suggests potential financial risk, especially in an environment of rising interest rates. Despite this, the company recorded a current ratio of 1.06, indicating adequate short-term liquidity, while the quick ratio of 0.71 highlights potential liquidity constraints when excluding inventory. The book value per share decreased slightly to ₹55.81 in March 2025 from ₹61.23 in March 2024, reflecting the impact of debt on shareholder equity. The operating profit margin of 8% for the TTM period shows a modest improvement, yet concerns remain regarding the sustainability of financial leverage and its implications for future growth. The financial ratios indicate a mixed picture of potential growth tempered by high debt levels.
Shareholding Pattern and Investor Confidence
HCP Plastene’s shareholding pattern shows a stable promoter holding of 75% as of March 2025, which aligns with their long-term commitment to the company. The foreign institutional investors (FIIs) represent a minimal 0.07%, indicating low foreign interest, while domestic institutional investors (DIIs) hold 4.80%. The public shareholding stands at 20.13%, with a total of 5,147 shareholders as of March 2025, reflecting a diverse ownership base. The recent increase in public shareholding from 6.04% in September 2022 to 20.13% suggests growing investor confidence. The fluctuations in the number of shareholders, which peaked at 5,282 in March 2025, indicate active interest in the stock, although the low FII participation may limit broader market support. This ownership structure could provide stability, but the reliance on domestic investors poses risks if sentiment shifts. Overall, the shareholding pattern indicates a cautiously optimistic investor outlook, with significant room for improvement in attracting institutional investors.
Outlook, Risks, and Final Insight
If margins sustain their upward trend and the company effectively manages its cash conversion cycle, HCP Plastene could leverage its operational improvements to enhance profitability further. However, the high debt levels pose significant risks, particularly in a rising interest rate environment, which may impact financial stability. Additionally, the volatility in sales figures suggests that maintaining consistent revenue growth will be crucial. The company must also address efficiency challenges to improve its CCC and overall operational effectiveness. If the management can successfully navigate these risks while capitalizing on growing market opportunities, it may position itself favorably for long-term growth. However, close monitoring of financial leverage and market conditions will be essential to ensure that the upward trends in profitability do not reverse due to external economic pressures.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of HCP Plastene Bulkpack Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HCP Plastene Bulkpack Ltd | 174 Cr. | 163 | 216/88.8 | 14.4 | 55.8 | 0.00 % | 13.2 % | 17.7 % | 10.0 |
| Time Technoplast Ltd | 10,088 Cr. | 222 | 257/153 | 25.0 | 63.7 | 0.56 % | 17.4 % | 14.2 % | 1.00 |
| Huhtamaki India Ltd | 1,774 Cr. | 235 | 410/170 | 24.3 | 163 | 0.85 % | 7.14 % | 5.15 % | 2.00 |
| Flexituff Ventures International Ltd | 70.5 Cr. | 21.6 | 81.4/17.3 | 4.48 | 0.00 % | 8.07 % | % | 10.0 | |
| Industry Average | 4,012.00 Cr | 160.40 | 21.23 | 71.75 | 0.35% | 11.45% | 12.35% | 5.75 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 111.04 | 93.80 | 69.46 | 77.22 | 59.37 | 78.87 | 79.68 | 76.63 | 104.70 | 117.08 | 119.37 | 122.28 | 125.75 |
| Expenses | 106.05 | 89.70 | 66.00 | 74.11 | 57.99 | 74.03 | 74.69 | 71.15 | 98.11 | 109.57 | 111.18 | 109.36 | 116.59 |
| Operating Profit | 4.99 | 4.10 | 3.46 | 3.11 | 1.38 | 4.84 | 4.99 | 5.48 | 6.59 | 7.51 | 8.19 | 12.92 | 9.16 |
| OPM % | 4.49% | 4.37% | 4.98% | 4.03% | 2.32% | 6.14% | 6.26% | 7.15% | 6.29% | 6.41% | 6.86% | 10.57% | 7.28% |
| Other Income | 1.86 | 0.10 | 0.02 | 0.32 | 0.25 | 0.89 | 0.20 | 1.22 | 1.30 | 0.57 | 0.93 | 1.88 | 6.51 |
| Interest | 1.90 | 2.06 | 2.32 | 3.10 | 2.50 | 2.72 | 3.07 | 3.45 | 3.33 | 3.43 | 3.97 | 3.89 | 4.16 |
| Depreciation | 1.77 | 1.82 | 1.95 | 1.84 | 1.80 | 1.89 | 1.81 | 1.80 | 1.71 | 1.70 | 2.06 | 1.82 | 1.82 |
| Profit before tax | 3.18 | 0.32 | -0.79 | -1.51 | -2.67 | 1.12 | 0.31 | 1.45 | 2.85 | 2.95 | 3.09 | 9.09 | 9.69 |
| Tax % | 33.02% | 56.25% | -32.91% | -37.09% | -19.85% | 14.29% | 6.45% | 16.55% | 26.32% | 26.44% | 28.80% | -15.95% | 26.42% |
| Net Profit | 2.13 | 0.12 | -0.55 | -0.95 | -2.14 | 0.96 | 0.28 | 1.21 | 2.10 | 2.18 | 2.20 | 10.54 | 7.13 |
| EPS in Rs | 0.37 | -1.00 | -0.23 | -1.22 | -1.41 | 0.21 | -0.42 | 0.52 | 1.36 | 1.41 | 1.41 | 4.72 | 3.76 |
Last Updated: August 19, 2025, 1:55 pm
Below is a detailed analysis of the quarterly data for HCP Plastene Bulkpack Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 125.75 Cr.. The value appears strong and on an upward trend. It has increased from 122.28 Cr. (Mar 2025) to 125.75 Cr., marking an increase of 3.47 Cr..
- For Expenses, as of Jun 2025, the value is 116.59 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 109.36 Cr. (Mar 2025) to 116.59 Cr., marking an increase of 7.23 Cr..
- For Operating Profit, as of Jun 2025, the value is 9.16 Cr.. The value appears to be declining and may need further review. It has decreased from 12.92 Cr. (Mar 2025) to 9.16 Cr., marking a decrease of 3.76 Cr..
- For OPM %, as of Jun 2025, the value is 7.28%. The value appears to be declining and may need further review. It has decreased from 10.57% (Mar 2025) to 7.28%, marking a decrease of 3.29%.
- For Other Income, as of Jun 2025, the value is 6.51 Cr.. The value appears strong and on an upward trend. It has increased from 1.88 Cr. (Mar 2025) to 6.51 Cr., marking an increase of 4.63 Cr..
- For Interest, as of Jun 2025, the value is 4.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.89 Cr. (Mar 2025) to 4.16 Cr., marking an increase of 0.27 Cr..
- For Depreciation, as of Jun 2025, the value is 1.82 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.82 Cr..
- For Profit before tax, as of Jun 2025, the value is 9.69 Cr.. The value appears strong and on an upward trend. It has increased from 9.09 Cr. (Mar 2025) to 9.69 Cr., marking an increase of 0.60 Cr..
- For Tax %, as of Jun 2025, the value is 26.42%. The value appears to be increasing, which may not be favorable. It has increased from -15.95% (Mar 2025) to 26.42%, marking an increase of 42.37%.
- For Net Profit, as of Jun 2025, the value is 7.13 Cr.. The value appears to be declining and may need further review. It has decreased from 10.54 Cr. (Mar 2025) to 7.13 Cr., marking a decrease of 3.41 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.76. The value appears to be declining and may need further review. It has decreased from 4.72 (Mar 2025) to 3.76, marking a decrease of 0.96.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 12:57 pm
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Sales | 16 | 112 | 351 | 295 | 463 | 484 |
| Expenses | 19 | 106 | 334 | 278 | 428 | 447 |
| Operating Profit | -3 | 6 | 18 | 17 | 35 | 38 |
| OPM % | -20% | 5% | 5% | 6% | 8% | 8% |
| Other Income | 53 | 1 | 1 | 3 | 5 | 10 |
| Interest | 1 | 4 | 10 | 12 | 15 | 15 |
| Depreciation | 5 | 5 | 7 | 7 | 7 | 7 |
| Profit before tax | 44 | -3 | 1 | 0 | 18 | 25 |
| Tax % | -46% | -22% | 36% | -55% | 26% | |
| Net Profit | 64 | -2 | 1 | 0 | 13 | 22 |
| EPS in Rs | 38.79 | -2.86 | -2.07 | -1.11 | 9.02 | 11.30 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|
| YoY Net Profit Growth (%) | -103.12% | 150.00% | -100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 253.12% | -250.00% |
HCP Plastene Bulkpack Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 3 years from 2021-2022 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 60% |
| TTM: | 43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 73% |
| TTM: | 577% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 110% |
| 3 Years: | -28% |
| 1 Year: | 2% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 4% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 3:41 pm
Balance Sheet
Last Updated: July 25, 2025, 1:07 pm
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 11 | 11 | 11 |
| Reserves | 16 | 15 | 39 | 39 | 49 |
| Borrowings | 38 | 109 | 123 | 158 | 190 |
| Other Liabilities | 8 | 39 | 27 | 25 | 26 |
| Total Liabilities | 72 | 174 | 200 | 233 | 276 |
| Fixed Assets | 27 | 79 | 84 | 77 | 73 |
| CWIP | 0 | 0 | 1 | 4 | 0 |
| Investments | 0 | 0 | 1 | 1 | 1 |
| Other Assets | 45 | 94 | 115 | 152 | 203 |
| Total Assets | 72 | 174 | 200 | 233 | 276 |
Below is a detailed analysis of the balance sheet data for HCP Plastene Bulkpack Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
- For Reserves, as of Mar 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Mar 2024) to 49.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Mar 2025, the value is 190.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 158.00 Cr. (Mar 2024) to 190.00 Cr., marking an increase of 32.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.00 Cr. (Mar 2024) to 26.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 276.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 233.00 Cr. (Mar 2024) to 276.00 Cr., marking an increase of 43.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 73.00 Cr.. The value appears to be declining and may need further review. It has decreased from 77.00 Cr. (Mar 2024) to 73.00 Cr., marking a decrease of 4.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 4.00 Cr..
- For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
- For Other Assets, as of Mar 2025, the value is 203.00 Cr.. The value appears strong and on an upward trend. It has increased from 152.00 Cr. (Mar 2024) to 203.00 Cr., marking an increase of 51.00 Cr..
- For Total Assets, as of Mar 2025, the value is 276.00 Cr.. The value appears strong and on an upward trend. It has increased from 233.00 Cr. (Mar 2024) to 276.00 Cr., marking an increase of 43.00 Cr..
However, the Borrowings (190.00 Cr.) are higher than the Reserves (49.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Free Cash Flow | -41.00 | -103.00 | -105.00 | -141.00 | -155.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debtor Days | 76 | 87 | 29 | 70 | 71 |
| Inventory Days | 225 | 115 | 38 | 65 | 61 |
| Days Payable | 245 | 94 | 10 | 7 | -1 |
| Cash Conversion Cycle | 56 | 108 | 57 | 129 | 133 |
| Working Capital Days | 85 | 43 | 28 | -5 | 7 |
| ROCE % | 1% | 6% | 6% | 13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 12.51 | 0.37 | 1.06 | -2.39 | 65.80 |
| Diluted EPS (Rs.) | 9.02 | 0.37 | 1.01 | -2.39 | 65.80 |
| Cash EPS (Rs.) | 19.34 | 7.12 | 7.63 | 2.73 | 67.17 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 55.81 | 61.23 | 60.39 | 36.08 | 25.70 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 55.81 | 61.23 | 60.39 | 36.08 | 25.70 |
| Revenue From Operations / Share (Rs.) | 434.14 | 275.94 | 329.30 | 109.63 | 15.51 |
| PBDIT / Share (Rs.) | 37.39 | 18.01 | 16.65 | 5.84 | -3.42 |
| PBIT / Share (Rs.) | 30.56 | 11.18 | 9.73 | 0.72 | -8.43 |
| PBT / Share (Rs.) | 16.86 | 0.18 | 1.11 | -3.09 | 42.53 |
| Net Profit / Share (Rs.) | 12.51 | 0.28 | 0.71 | -2.39 | 62.17 |
| NP After MI And SOA / Share (Rs.) | 9.02 | -1.11 | -2.07 | -2.39 | 62.17 |
| PBDIT Margin (%) | 8.61 | 6.52 | 5.05 | 5.33 | -22.05 |
| PBIT Margin (%) | 7.03 | 4.04 | 2.95 | 0.65 | -54.33 |
| PBT Margin (%) | 3.88 | 0.06 | 0.33 | -2.81 | 274.26 |
| Net Profit Margin (%) | 2.88 | 0.10 | 0.21 | -2.18 | 400.86 |
| NP After MI And SOA Margin (%) | 2.07 | -0.40 | -0.62 | -2.18 | 400.86 |
| Return on Networth / Equity (%) | 16.15 | -2.39 | -4.41 | -9.54 | 241.85 |
| Return on Capital Employeed (%) | 28.33 | 10.45 | 6.92 | 0.59 | -13.40 |
| Return On Assets (%) | 3.48 | -0.50 | -1.10 | -1.41 | 87.93 |
| Long Term Debt / Equity (X) | 0.54 | 0.96 | 1.63 | 3.42 | 1.44 |
| Total Debt / Equity (X) | 3.19 | 3.19 | 2.44 | 4.24 | 1.44 |
| Asset Turnover Ratio (%) | 1.82 | 1.36 | 1.88 | 0.64 | 0.00 |
| Current Ratio (X) | 1.06 | 0.97 | 1.56 | 1.24 | 1.50 |
| Quick Ratio (X) | 0.71 | 0.67 | 1.02 | 0.72 | 0.68 |
| Inventory Turnover Ratio (X) | 7.62 | 6.74 | 6.67 | 5.49 | 0.00 |
| Interest Coverage Ratio (X) | 2.73 | 1.64 | 1.89 | 1.53 | -2.76 |
| Interest Coverage Ratio (Post Tax) (X) | 1.91 | 1.03 | 1.06 | 0.37 | 9.05 |
| Enterprise Value (Cr.) | 319.31 | 372.53 | 338.47 | 713.16 | 47.08 |
| EV / Net Operating Revenue (X) | 0.68 | 1.26 | 0.96 | 6.36 | 2.97 |
| EV / EBITDA (X) | 8.00 | 19.38 | 19.05 | 119.23 | -13.45 |
| MarketCap / Net Operating Revenue (X) | 0.23 | 0.67 | 0.57 | 5.29 | 0.58 |
| Price / BV (X) | 1.85 | 4.03 | 4.05 | 23.13 | 0.35 |
| Price / Net Operating Revenue (X) | 0.23 | 0.67 | 0.57 | 5.29 | 0.58 |
| EarningsYield | 0.08 | -0.01 | -0.01 | 0.00 | 6.83 |
After reviewing the key financial ratios for HCP Plastene Bulkpack Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.51. This value is within the healthy range. It has increased from 0.37 (Mar 24) to 12.51, marking an increase of 12.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is 9.02. This value is within the healthy range. It has increased from 0.37 (Mar 24) to 9.02, marking an increase of 8.65.
- For Cash EPS (Rs.), as of Mar 25, the value is 19.34. This value is within the healthy range. It has increased from 7.12 (Mar 24) to 19.34, marking an increase of 12.22.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.81. It has decreased from 61.23 (Mar 24) to 55.81, marking a decrease of 5.42.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.81. It has decreased from 61.23 (Mar 24) to 55.81, marking a decrease of 5.42.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 434.14. It has increased from 275.94 (Mar 24) to 434.14, marking an increase of 158.20.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 37.39. This value is within the healthy range. It has increased from 18.01 (Mar 24) to 37.39, marking an increase of 19.38.
- For PBIT / Share (Rs.), as of Mar 25, the value is 30.56. This value is within the healthy range. It has increased from 11.18 (Mar 24) to 30.56, marking an increase of 19.38.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.86. This value is within the healthy range. It has increased from 0.18 (Mar 24) to 16.86, marking an increase of 16.68.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.51. This value is within the healthy range. It has increased from 0.28 (Mar 24) to 12.51, marking an increase of 12.23.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 9.02. This value is within the healthy range. It has increased from -1.11 (Mar 24) to 9.02, marking an increase of 10.13.
- For PBDIT Margin (%), as of Mar 25, the value is 8.61. This value is below the healthy minimum of 10. It has increased from 6.52 (Mar 24) to 8.61, marking an increase of 2.09.
- For PBIT Margin (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 10. It has increased from 4.04 (Mar 24) to 7.03, marking an increase of 2.99.
- For PBT Margin (%), as of Mar 25, the value is 3.88. This value is below the healthy minimum of 10. It has increased from 0.06 (Mar 24) to 3.88, marking an increase of 3.82.
- For Net Profit Margin (%), as of Mar 25, the value is 2.88. This value is below the healthy minimum of 5. It has increased from 0.10 (Mar 24) to 2.88, marking an increase of 2.78.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.07. This value is below the healthy minimum of 8. It has increased from -0.40 (Mar 24) to 2.07, marking an increase of 2.47.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.15. This value is within the healthy range. It has increased from -2.39 (Mar 24) to 16.15, marking an increase of 18.54.
- For Return on Capital Employeed (%), as of Mar 25, the value is 28.33. This value is within the healthy range. It has increased from 10.45 (Mar 24) to 28.33, marking an increase of 17.88.
- For Return On Assets (%), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 5. It has increased from -0.50 (Mar 24) to 3.48, marking an increase of 3.98.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has decreased from 0.96 (Mar 24) to 0.54, marking a decrease of 0.42.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 1. There is no change compared to the previous period (Mar 24) which recorded 3.19.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.82. It has increased from 1.36 (Mar 24) to 1.82, marking an increase of 0.46.
- For Current Ratio (X), as of Mar 25, the value is 1.06. This value is below the healthy minimum of 1.5. It has increased from 0.97 (Mar 24) to 1.06, marking an increase of 0.09.
- For Quick Ratio (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.67 (Mar 24) to 0.71, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.62. This value is within the healthy range. It has increased from 6.74 (Mar 24) to 7.62, marking an increase of 0.88.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.73. This value is below the healthy minimum of 3. It has increased from 1.64 (Mar 24) to 2.73, marking an increase of 1.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 3. It has increased from 1.03 (Mar 24) to 1.91, marking an increase of 0.88.
- For Enterprise Value (Cr.), as of Mar 25, the value is 319.31. It has decreased from 372.53 (Mar 24) to 319.31, marking a decrease of 53.22.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has decreased from 1.26 (Mar 24) to 0.68, marking a decrease of 0.58.
- For EV / EBITDA (X), as of Mar 25, the value is 8.00. This value is within the healthy range. It has decreased from 19.38 (Mar 24) to 8.00, marking a decrease of 11.38.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.67 (Mar 24) to 0.23, marking a decrease of 0.44.
- For Price / BV (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has decreased from 4.03 (Mar 24) to 1.85, marking a decrease of 2.18.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.67 (Mar 24) to 0.23, marking a decrease of 0.44.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.08, marking an increase of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in HCP Plastene Bulkpack Ltd:
- Net Profit Margin: 2.88%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 28.33% (Industry Average ROCE: 11.45%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.15% (Industry Average ROE: 12.35%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.91
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.71
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.4 (Industry average Stock P/E: 21.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.88%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Packaging & Containers | H B Jirawala House, 13 Nav Bharat Society, Ahmedabad Gujarat 380013 | cs@gopalapolyplast.com http://www.gopalapolyplast.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anil Shyamsunder Goyal | Chairman |
| Mr. Prakash Hiralal Parekh | Managing Director |
| Mr. Sandeep Motilal Shah | Ind. Non-Executive Director |
| Ms. Meenu Maheshwari | Ind. Non-Executive Director |
| Mr. Ashutosh Maheshwari | Ind. Non-Executive Director |
| Dr. Ranjeet Mal kastia | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of HCP Plastene Bulkpack Ltd?
HCP Plastene Bulkpack Ltd's intrinsic value (as of 10 October 2025) is 116.05 which is 28.80% lower the current market price of 163.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹174 Cr. market cap, FY2025-2026 high/low of 216/88.8, reserves of ₹49 Cr, and liabilities of 276 Cr.
What is the Market Cap of HCP Plastene Bulkpack Ltd?
The Market Cap of HCP Plastene Bulkpack Ltd is 174 Cr..
What is the current Stock Price of HCP Plastene Bulkpack Ltd as on 10 October 2025?
The current stock price of HCP Plastene Bulkpack Ltd as on 10 October 2025 is 163.
What is the High / Low of HCP Plastene Bulkpack Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of HCP Plastene Bulkpack Ltd stocks is 216/88.8.
What is the Stock P/E of HCP Plastene Bulkpack Ltd?
The Stock P/E of HCP Plastene Bulkpack Ltd is 14.4.
What is the Book Value of HCP Plastene Bulkpack Ltd?
The Book Value of HCP Plastene Bulkpack Ltd is 55.8.
What is the Dividend Yield of HCP Plastene Bulkpack Ltd?
The Dividend Yield of HCP Plastene Bulkpack Ltd is 0.00 %.
What is the ROCE of HCP Plastene Bulkpack Ltd?
The ROCE of HCP Plastene Bulkpack Ltd is 13.2 %.
What is the ROE of HCP Plastene Bulkpack Ltd?
The ROE of HCP Plastene Bulkpack Ltd is 17.7 %.
What is the Face Value of HCP Plastene Bulkpack Ltd?
The Face Value of HCP Plastene Bulkpack Ltd is 10.0.